Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Johansson
S. Johansson
Janssen Pharmaceutica
Medicine
Ribavirin
Virology
Fibrosis
Immunology
4
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients.
2015
Alimentary Pharmacology & Therapeutics
S. Johansson
Willem Talloen
M. Tuefferd
Jama M. Darling
A. Scholliers
Gregory Fanning
Michael W. Fried
Jeroen Aerssens
Show All
Source
Cite
Save
Citations (11)
P1189 HIGH MIG (CXCL9) PLASMA LEVEL FAVORS RESPONSE TO PEGINTERFERON AND RIBAVIRIN IN HCV INFECTED PATIENTS BUT IS NOT LINKED TO DPP4 ACTIVITY
2014
Journal of Hepatology
S. Johansson
Willem Talloen
M. Tuefferd
Jama M. Darling
Gregory Fanning
M.W. Fried
Jeroen Aerssens
Show All
Source
Cite
Save
Citations (0)
P767 PLASMA LEVELS OF GRO ASSOCIATE WITH FIBROSIS AND PLATELET COUNTS IN HCV INFECTED PATIENTS FROM THE VIRAHEP-C COHORT
2014
Journal of Hepatology
S. Johansson
Willem Talloen
M. Tuefferd
Jama M. Darling
Annick Scholliers
Gregory Fanning
M.W. Fried
Jeroen Aerssens
Show All
Source
Cite
Save
Citations (0)
1167 PRE-TREATMENT IP-10 LEVELS AND IL28B GENOTYPE IN PREDICTION OF SVR IN PRIOR TREATMENT-EXPERIENCED GENOTYPE 1 HCV PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN IN THE REALIZE STUDY
2012
Journal of Hepatology
L. Vijgen
Willem Talloen
Annick Scholliers
S. Johansson
M. Tuefferd
S. De Meyer
James Witek
Gregory Fanning
Gaston Picchio
Stanislas Pol
Stefan Zeuzem
Jeroen Aerssens
Show All
Source
Cite
Save
Citations (5)
1